Bioactive Peptide Market to Surpass US$ 7,335.8 Mn by 2026 - Coherent Market Insights

Global Bioactive Peptide Market, by Source (Plant, Milk, Eggs, Meat, Fish and Others), by Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others ), by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa), was valued at US$ 3,265.2 million in 2017, and is projected to exhibit a CAGR of 9.4% over the forecast period (2018–2026), as highlighted in a new report published by .

Bioactive peptides are incorporated in dietary supplements, pharmaceuticals, and novel food supplements. Such formulations tailored with health benefits are used extensively across the globe to optimize health outcomes.

Collagen peptides are now being incorporated into a variety of sports and active nutrition products to improve physical performance of athletes. In March 2019, Gelita launched the collagen peptide which can be used in a variety of functional and nutritional beverages. Moreover collagen peptide are easily absorbed by body and are highly bioavailable.

According to a research report by the Massachusetts Institute of Technology (MIT), U.S. published on Feb 2017, researchers have designed a machine that can rapidly produce large quantities of customized peptides. The new tabletop machine can form links between amino acids in about 37 seconds, and it takes less than an hour to generate complete peptide molecules containing up to 60 amino acids.

Rising demand for cost effective, fast relief, and products beneficial for health is driving research and development activities. According to study published on July 2017 in the Nature research Journal, scientists have developed a synthetic peptide that can specifically inhibit Zika virus infection. The researchers have synthesized a peptide (Z2) derived from the envelop protein that exhibits inhibitory effects on Zika virus infection.

Browse 36 Market Data Tables and 30 Figures spread through 167 Pages and in-depth TOC on “Bioactive Peptide Market”- Global Forecast to 2026, by Source (Plant, Milk, Eggs, Meat, Fish, and Others), by Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa),

To know the latest trends and insights prevalent in the global bioactive peptide market, click the link below:

https://www.coherentmarketinsights.com/market-insight/bioactive-peptide-market-3018

Market players are focused on development of novel products, through partnerships and agreements. For instance, in July 2019, Nuritas and Stonehaven Incubate entered a partnership agreement for development of advanced animal health solutions, with an initial focus on animal feed ingredient. Nuritas Ltd. combines artificial intelligence and genomics to discover and unlock natural Bioactive Peptides with extraordinary health benefits.

Key Takeaways of the Global Bioactive peptide Market:

• The global bioactive peptide market is expected to exhibit a CAGR of 9.4% over the forecast period owing to increasing awareness and reliability on bioactive products is offering a strong consumer base for the market. Bioactive ingredients are essential for various health purposes, and to prevent chronic diseases that may occur due to lack of required nutrients in the body.
• Among source, the plant-based bioactive peptide segment held the higher market share in 2018, owing to rising demand for effective as well as quality products, combined with technological advancements.
• Among therapeutic area, the antihypertensive segment held the higher market share in 2018 owing to rising prevalence of cardiovascular diseases such as coronary artery disease, congenital heart failure, and angina
• Companies operating in the global bioactive peptide market include Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., and Valio Oy among others.